Design Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Design Pharmaceuticals, Inc. - overview
Established
2018
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2018 by Dirk Loeffert (CEO), Design Pharmaceuticals, Inc. , doing business as, Design Pharma, is involved in small molecule drug research and development by utilizing biotechnologies to gain access to previously undiscovered molecules and speed up the drug discovery process. In January 2022, Design Pharmaceuticals, Inc. raised USD 3 million in Seed funding led by new investor Virtus Inspire Ventures.
The company is a biotech firm that discovers small molecule drug compounds. The firm uses AI-guided biomining to screen compounds for G-protein coupled receptor (GPCR) screening from molecular sources such as chemical compound libraries, peptide and antibody libraries, DNA-encoded libraries, or patient samples, and build compounds to test various chemical structures built and biosynthetically create better compound candidates. The company intends to use the January 2022 funding to further improve its discovery platform and operations.
Current Investors
Virtus Inspire Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Website
www.designpharmaceuticals.com
Verticals
Artificial Intelligence
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.